Medical imaging (MRI and spectral CT)primary
3 projects
SPCCT focused on spectral photon counting CT, OpenGTN on MRI simulation for training, and LIMA combined MRI with liquid biopsies for cancer care.
Organization
PHILIPS GMBH
German Philips subsidiary contributing medical imaging (MRI, spectral CT), cancer diagnostics, and cyber-physical systems expertise to European research consortia.
Large industrial companyhealthDE
H2020 projects
7
As coordinator
0
Total EC funding
€1.5M
Unique partners
129
What they do
Their core work
Philips GmbH is the Hamburg-based German subsidiary of Royal Philips, a global health technology company. In the H2020 context, they contribute advanced medical imaging expertise — particularly MRI and spectral CT — to research consortia tackling cancer diagnostics, heart valve disease, and liquid biopsy technologies. Beyond healthcare, they bring industrial engineering capabilities in areas like composite manufacturing, laser processing, and more recently cyber-physical systems for safety-critical applications.
Core expertise
What they specialise in
Cancer diagnostics and liquid biopsyprimary
2 projects
LIMA targeted liquid biopsy (ct-DNA, CTC) for breast and rectal cancer monitoring, while SPCCT advanced molecular imaging for cardiovascular and neurovascular disease.
Clinical decision support systemssecondary
1 project
EurValve developed personalised decision support for heart valve disease, combining patient data with computational models.
Advanced manufacturing and compositessecondary
1 project
ComMUnion developed multi-material metal-thermoplastic joining using laser-assisted tape placement, multi-scale modelling, and automated inspection.
Cyber-physical systems and edge computingemerging
1 project
TRANSACT (2021-2024) addresses safety-critical cyber-physical systems with distributed edge computing solutions — their most recent project.
Smart energy and urban sustainabilitysecondary
1 project
GrowSmarter was a lighthouse smart city project focused on energy saving, demonstration, and replication across European cities.
Evolution & trajectory
How they've shifted over time
Early focus
Energy and advanced manufacturing
Recent focus
Health imaging and digital systems
In the early period (2015-2017), Philips GmbH participated in diverse industrial topics: smart city energy efficiency (GrowSmarter) and advanced composite manufacturing with laser processing (ComMUnion). From 2016 onward, they shifted decisively toward health technology — medical imaging, cancer diagnostics, and liquid biopsies became their dominant focus. Their most recent project (TRANSACT, 2021) signals an emerging interest in distributed cyber-physical systems and edge computing, potentially linking their health-tech imaging systems to modern distributed architectures.
Philips GmbH is converging on the intersection of medical imaging, diagnostic AI, and distributed cyber-physical infrastructure — expect future work combining health-tech with edge computing.
Collaboration profile
How they like to work
Role: specialist_contributorReach: European20 countries collaborated
Philips GmbH participates exclusively as a consortium partner, never as coordinator, suggesting they contribute specialized technical capabilities rather than driving project management. With 129 unique partners across 20 countries in just 7 projects, they operate in large, diverse consortia — typical of a major industrial player lending domain expertise to ambitious multi-partner research efforts. Their broad partner network and non-repeated consortia indicate they are sought after for their specific technical contributions rather than building a tight-knit research cluster.
Philips GmbH has collaborated with 129 unique partners across 20 countries, an exceptionally wide network for just 7 projects. This reflects their participation in large-scale European consortia with strong pan-European reach and no narrow geographic bias.
Why partner with them
What sets them apart
As a subsidiary of a global health technology leader, Philips GmbH brings production-grade medical imaging expertise (MRI, spectral CT) that few academic or SME partners can match. They bridge the gap between clinical research and industrial-scale medical device development, making them a credible path from prototype to market. Their combination of imaging hardware knowledge, software capabilities, and manufacturing experience is rare in a single consortium partner.
Notable projects
Highlights from their portfolio
- SPCCTLargest single EC contribution (EUR 442,375) and focused on next-generation spectral photon counting CT — a technology Philips is developing commercially.
- LIMACombines liquid biopsy with MRI imaging for cancer care, representing Philips' convergence of diagnostic imaging and molecular diagnostics.
- TRANSACTTheir most recent project (2021-2024), signaling a strategic move into distributed cyber-physical systems and edge computing for safety-critical applications.
Cross-sector capabilities
Manufacturing — laser processing and composite materialsDigital — cyber-physical systems and edge computingEnergy — smart city and energy efficiency solutionsTransport — safety-critical distributed systems
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →